220
Participants
Start Date
September 15, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
December 31, 2029
Avatrombopag
Daily tablets
Rituximab (Arm B)
I.V.
Oslo University Hospital
OTHER
University Hospital, Akershus
OTHER
Sykehuset i Vestfold HF
OTHER
St. Olavs Hospital
OTHER
Helse Stavanger HF
OTHER_GOV
Sorlandet Hospital HF
OTHER_GOV
University Hospital of North Norway
OTHER
Haukeland University Hospital
OTHER
Helse Nord-Trøndelag HF
OTHER
Helse Fonna
OTHER
Nordlandssykehuset HF
OTHER
Ostfold Hospital Trust
OTHER